Company

Precision BioSciences ($DTIL)

  • Biotech

Overview

Develops ARCUS genome-editing medicines that insert, remove, or repair DNA, targeting hard-to-treat conditions including Duchenne muscular dystrophy and hepatitis B.

Part of the Research Triangle ecosystem